MECANISMOS DE SEÑALIZACIÓN EN ENFERMEDADES CARDIOVASCULARES Y OTRAS PATOLOGÍAS: DE LA INVESTIGACIÓN BÁSICA A LA CLÍNICA
Hospital Universitari Germans Trias i Pujol
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (9)
2021
-
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients
Blood Cells, Molecules, and Diseases, Vol. 86
-
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)
Scientific Reports
2019
2015
-
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score
Leukemia Research, Vol. 39, Núm. 1, pp. 52-57
-
Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia
Annals of Hematology, Vol. 94, Núm. 6, pp. 911-918
-
Rivaroxaban in the treatment of venous thromboembolism and the prevention of recurrences: A practical approach
Clinical and Applied Thrombosis/Hemostasis, Vol. 21, Núm. 4, pp. 297-308
2014
-
Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs
Journal of Vascular Surgery, Vol. 59, Núm. 5
2013
-
Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome
Leukemia Research, Vol. 37, Núm. 7, pp. 769-776
2012
-
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome
Cancer, Vol. 118, Núm. 1, pp. 127-133